NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 412 filers reported holding NOVAVAX INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,405 | +96.2% | 2,404 | +101.3% | 0.00% | – |
| Q2 2023 | $8,872 | +154.4% | 1,194 | +137.4% | 0.00% | – |
| Q1 2023 | $3,487 | -19.0% | 503 | +20.0% | 0.00% | – |
| Q4 2022 | $4,306 | -64.1% | 419 | -38.8% | 0.00% | – |
| Q3 2022 | $12,000 | -70.0% | 685 | -10.5% | 0.00% | – |
| Q2 2022 | $40,000 | -41.2% | 765 | -17.2% | 0.00% | – |
| Q1 2022 | $68,000 | -58.5% | 924 | -18.8% | 0.00% | – |
| Q4 2021 | $164,000 | -52.3% | 1,138 | -31.4% | 0.00% | – |
| Q3 2021 | $344,000 | -6.5% | 1,658 | -4.5% | 0.00% | – |
| Q2 2021 | $368,000 | +67.3% | 1,736 | +42.5% | 0.00% | – |
| Q1 2021 | $220,000 | +117.8% | 1,218 | +33.6% | 0.00% | – |
| Q4 2020 | $101,000 | +17.4% | 912 | +15.2% | 0.00% | – |
| Q3 2020 | $86,000 | +41.0% | 792 | +9.2% | 0.00% | – |
| Q2 2020 | $61,000 | +1933.3% | 725 | +222.2% | 0.00% | – |
| Q1 2020 | $3,000 | – | 225 | +2150.0% | 0.00% | – |
| Q4 2019 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |